Candidiasis peritoneal: prevalencia y factores de riesgo

Aguado, 2011, Recomendaciones sobre el tratamiento de la candidiasis invasiva y otras infecciones por levaduras de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011, Enferm Infecc Microbiol Clin, 29, 345, 10.1016/j.eimc.2011.01.008 Ayats, 2011, Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010, Enferm Infecc Microbiol Clin, 29, 39, 10.1016/j.eimc.2010.08.005 Barthlen, 1992, Prognostic factors in diffuse peritonitis, Langenbecks Arch Chir, 377, 89, 10.1007/BF00184341 Bayer, 1976, Candida peritonitis. Report of 22 cases and review of the English literature, Am J Med, 61, 832, 10.1016/0002-9343(76)90407-1 Blot, 2007, Candida peritonitis, Curr Opin Crit Care, 13, 195, 10.1097/MCC.0b013e328028fd92 Dupont, 2003, Can yeast isolation in peritoneal fluid be predictive in intensive care unit patients with peritonitis?, Crit Care Med, 31, 752, 10.1097/01.CCM.0000053525.49267.77 Garnacho, 2005, Resumen de las recomendaciones terapéuticas para infecciones fúngicas en el paciente crítico no neutropénico: una visión multidisciplinar, Farm Hosp, 29, 283, 10.1016/S1130-6343(05)73677-1 Guirao, 2009, Recomendaciones en el tratamiento antibiótico empírico de la infección intraabdominal, Rev Esp Quimioter, 22, 151 Hsu, 2009, Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery, J Microbiol Immunol Infect, 42, 378 León, 2009, Diferenciación entre candidiasis invasiva y colonización por Candida: “Candida score”, REMI, 9, 1364 Leroy, 2009, Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observacional study in France (2005-2006), Cri Care Med, 37, 1612, 10.1097/CCM.0b013e31819efac0 Magill, 2009, The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: Follow-up to a randomized clinical trial, Ann Surg, 249, 657, 10.1097/SLA.0b013e31819ed914 Montravers, 2006, Candida as a risk factor for mortality in peritonitis, Crit Care Med, 34, 646, 10.1097/01.CCM.0000201889.39443.D2 Montravers, 2011, A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units, Clin Microbiol Infect, 17, 1061, 10.1111/j.1469-0691.2010.03360.x Nolla, 1997, Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy, Intensive Care Med, 23, 23, 10.1007/s001340050286 Ostrosky-Zeichner, 2006, Invasive candidiasis in the intensive care unit, Crit Care Med, 34, 857, 10.1097/01.CCM.0000201897.78123.44 Pappas, 2009, Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America, Clin Infect Dis, 48, 503, 10.1086/596757 Tactic, 2003, Role and importance of fungal infections in intensive care units, Med Pregl, 56, 537, 10.2298/MPNS0312537T Zaragoza, 2008, ¿Implica el aislamiento de Candida spp. en muestras intraabdominales de pacientes críticos la necesidad de tratamiento antifúngico?, Rev Iberoam Micol, 25, 203, 10.1016/S1130-1406(08)70049-4